Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Should PTSC inform shareholders of new Licencing Fee strategy?
Reply New Message
Back To Forum List View
Schrock & RIMM are obviously great news for us...

BaNosser
Apr 22, 2008 08:11AM
Re: Should PTSC inform shareholders of new Licencing Fee strategy?
4
srandl
Apr 22, 2008 08:25AM

Again, if they know this information and are restricted from disclosing it to us how can they be allowed to trade? Or are they?

DW

1 Recommendations
Re: Should PTSC inform shareholders of new Licencing Fee strategy?

B4-2012_please
Apr 22, 2008 08:37AM
Re: Should PTSC inform shareholders of new Licencing Fee strategy?

desert-weary
Apr 22, 2008 08:56AM
Re: Schrock & RIMM are obviously great news for us...

MagBeach
Apr 22, 2008 09:20AM
Re: Schrock & RIMM are obviously great news for us...

nezahualcoyotl2012
Apr 22, 2008 09:45AM
Is fhis good English?
2
Wings05
Apr 22, 2008 10:33AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply